Salarius Pharmaceuticals, Inc. [SLRX] has reported $0.0 in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $12.5 million.
Based in Houston, Texas, Salarius Pharmaceuticals, Inc. operates in the Manufacturing sector.